World Health Organization Director-General Dr. Tedros Adhanom Ghebreyesus held a special press briefing for UN-accredited journalists in Geneva on April 29, 2026 [1].
The briefing arrives as geopolitical tensions threaten coordinated international health responses, making the WHO's ability to operate across borders critical for pandemic prevention and crisis management.
Dr. Tedros addressed journalists accredited to the United Nations, known as ACANU, to discuss several urgent global health challenges. He said the health impacts resulting from the conflict in the Middle East and the ongoing crisis in Haiti are significant [1]. These regions face disruptions to medical infrastructure and basic healthcare access, issues that the WHO is attempting to mitigate through coordinated international action [1].
Beyond conflict zones, the Director-General detailed progress on specific medical initiatives. He said there are advancements in malaria treatment specifically for newborns and efforts to eliminate trachoma in Australia [1]. These updates signal a dual focus on eradicating neglected tropical diseases and improving neonatal care in high-risk areas [1].
Dr. Tedros also addressed the Pathogen Access and Benefit Sharing system, or PABS [1]. This system is designed to ensure the fair and equitable sharing of pathogens and the resulting benefits, such as vaccines and therapeutics, during future health emergencies [1].
Throughout the session, the Director-General emphasized the necessity of global cooperation. He said that the international community must prioritize health initiatives despite the prevailing geopolitical tensions to prevent further loss of life [1].
“The international community must prioritize health initiatives despite the prevailing geopolitical tensions.”
The briefing underscores the WHO's struggle to maintain a neutral, functional health infrastructure while navigating active conflict zones and diplomatic friction. By focusing on the PABS system and neonatal malaria treatments, the organization is attempting to build a more equitable global health framework that prevents wealthier nations from monopolizing medical breakthroughs during the next pandemic.
